Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

Individualized Obesity Pharmacotherapy

Novo Nordisk · Phase 3 · Completed · Enrollment 193

NCT03374956

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Intervention groupn/rn/rn/rn/r
Control Groupn/rn/rn/rn/r

Not shown

  • Intervention group: endpoint not reported
  • Control Group: endpoint not reported